News Medical on MSN6d
Why do people with obesity, but without diabetes, start taking semaglutide?
Research identifies key factors affecting semaglutide initiation among obese individuals without diabetes, revealing ...
Medscape9d
Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium–Glucose Cotransporter 2 Inhibition
Objective Sodium–glucose cotransporter 2 (SGLT-2) inhibitors are the most recently approved antihyperglycemic medications. We sought to describe their association with euglycemic diabetic ...
Hosted on MSN7mon
Differences in effectiveness among antihyperglycemic drugs on dementia risk identified in recent study
A recent study published in eClinical Medicine compares the effectiveness of anti-diabetes medications in reducing the risk of dementia in older diabetics. Study: Comparative effectiveness of ...
News Medical on MSN8d
Researchers create an atlas of health associations for GLP-1 receptor agonists
Insights from a study on GLP-1 receptor agonists reveal benefits for cardiometabolic health, with notable risks for ...